Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
J Cell Physiol ; 236(11): 7440-7449, 2021 11.
Article in English | MEDLINE | ID: mdl-34041746

ABSTRACT

Cardiac fibrosis accompanies a number of pathological conditions and results in altered myocardial structure, biomechanical properties and function. The signaling networks leading to fibrosis are complex, contributing to the general lack of progress in identifying effective therapeutic approaches to prevent or reverse this condition. Several studies have shown protective effects of emodin, a plant-derived anthraquinone, in animal models of fibrosis. A number of questions remain regarding the mechanisms whereby emodin impacts fibrosis. Transforming growth factor beta 1 (TGF-ß1) is a potent stimulus of fibrosis and fibroblast activation. In the present study, experiments were performed to evaluate the effects of emodin on activation and function of cardiac fibroblasts following treatment with TGF-ß1. We demonstrate that emodin attenuates TGF-ß1-induced fibroblast activation and collagen accumulation in vitro. Emodin also inhibits activation of several canonical (SMAD2/3) and noncanonical (Erk1/2) TGF-ß signaling pathways, while activating the p38 pathway. These results suggest that emodin may provide an effective therapeutic agent for fibrosis that functions via specific TGF-ß signaling pathways.


Subject(s)
Cell Movement/drug effects , Cell Proliferation/drug effects , Emodin/pharmacology , Fibroblasts/drug effects , Transforming Growth Factor beta1/pharmacology , Animals , Cells, Cultured , Collagen/metabolism , Fibroblasts/metabolism , Fibroblasts/pathology , Fibrosis , Male , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Myocardium/cytology , Rats, Sprague-Dawley , Signal Transduction , Smad2 Protein/metabolism , Smad3 Protein/metabolism , p38 Mitogen-Activated Protein Kinases/metabolism
2.
J Cell Physiol ; 234(8): 13931-13941, 2019 08.
Article in English | MEDLINE | ID: mdl-30609032

ABSTRACT

An important step in many pathological conditions, particularly tissue and organ fibrosis, is the conversion of relatively quiescent cells into active myofibroblasts. These are highly specialized cells that participate in normal wound healing but also contribute to pathogenesis. These cells possess characteristics of smooth muscle cells and fibroblasts, have enhanced synthetic activity secreting abundant extracellular matrix components, cytokines, and growth factors, and are capable of generating contractile force. As such, these cells have become potential therapeutic targets in a number of disease settings. Transforming growth factor ß (TGF-ß) is a potent stimulus of fibrosis and myofibroblast formation and likewise is an important therapeutic target in several disease conditions. The plant-derived isothiocyanate sulforaphane has been shown to have protective effects in several pathological models including diabetic cardiomyopathy, carcinogenesis, and fibrosis. These studies suggest that sulforaphane may be an attractive preventive agent against disease progression, particularly in conditions involving alterations of the extracellular matrix and activation of myofibroblasts. However, few studies have evaluated the effects of sulforaphane on cardiac fibroblast activation and their interactions with the extracellular matrix. The present studies were carried out to determine the potential effects of sulforaphane on the conversion of quiescent cardiac fibroblasts to an activated myofibroblast phenotype and associated alterations in signaling, expression of extracellular matrix receptors, and cellular physiology following stimulation with TGF-ß1. These studies demonstrate that sulforaphane attenuates TGF-ß1-induced myofibroblast formation and contractile activity. Sulforaphane also reduces expression of collagen-binding integrins and inhibits canonical and noncanonical TGF-ß signaling pathways.


Subject(s)
Extracellular Matrix/metabolism , Fibroblasts/metabolism , Isothiocyanates/pharmacology , Myocardium/cytology , Transforming Growth Factor beta1/pharmacology , Animals , Cattle , Collagen/pharmacology , Extracellular Matrix/drug effects , Extracellular Matrix Proteins/metabolism , Heme Oxygenase-1/genetics , Heme Oxygenase-1/metabolism , Hydrogels/pharmacology , Integrins/metabolism , Male , Matrix Metalloproteinases/metabolism , Rats, Sprague-Dawley , Signal Transduction/drug effects , Sulfoxides , Superoxide Dismutase/genetics , Superoxide Dismutase/metabolism
3.
Life Sci ; 92(11): 669-76, 2013 Mar 28.
Article in English | MEDLINE | ID: mdl-23333820

ABSTRACT

AIMS: Cardiovascular disease is the leading cause of death for individuals diagnosed with type II diabetes mellitus (DM). Changes in cardiac function, left ventricular wall thickness and fibrosis have all been described in patients and animal models of diabetes; however, the factors mediating increased matrix deposition remain unclear. The goal of this study was to evaluate whether cardiac fibroblast function is altered in a rat model of type II DM. MAIN METHODS: Cardiac fibroblasts were isolated from 14 week old Zucker diabetic and lean control (LC) adult male rat hearts. Fibroblasts were examined for their ability to remodel 3-dimensional collagen matrices, their adhesion, migration and proliferation on collagen and changes in gene expression associated with collagen remodeling. KEY FINDINGS: Cardiac fibroblasts from diabetic animals demonstrated significantly greater ability to contract 3-dimensional collagen matrices compared to cardiac fibroblasts from LC animals. The enhanced contractile behavior was associated with an increase in diabetic fibroblast proliferation and elevated expression of α-smooth muscle actin and type I collagen, suggesting the transformation of diabetic fibroblasts into a myofibroblast phenotype. SIGNIFICANCE: Cardiac fibrosis is a common complication in diabetic cardiomyopathy which may contribute to the observed cardiac dysfunction associated with this disease. Identifying and understanding the changes in fibroblast behavior which contribute to the increased deposition of collagen and other matrix proteins may provide novel therapeutic targets for reducing the devastating effects of diabetes on the heart.


Subject(s)
Diabetes Mellitus, Type 2/pathology , Fibroblasts/pathology , Myocardium/pathology , Myofibroblasts/pathology , Animals , Cell Adhesion , Cell Movement , Cell Proliferation , Cells, Cultured , Disease Models, Animal , Fibroblasts/cytology , Male , Myocardium/cytology , Phenotype , Polymerase Chain Reaction , Rats
4.
Cytokine ; 53(1): 19-28, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21050772

ABSTRACT

Fibroblasts are the primary cell type responsible for synthesis and remodeling of the extracellular matrix in the heart. A number of factors including growth factors, hormones and mechanical forces have been identified that modulate the production of extracellular matrix by cardiac fibroblasts. Inflammatory mediators including pro-inflammatory cytokines and chemokines also impact fibrosis of the heart. Recent studies have illustrated that interleukin-18 promotes a pro-fibrotic response in cardiac fibroblasts; however the effects of this cytokine on other aspects of fibroblast function have not been examined. While fibroblasts have long been known for their role in production and remodeling of the extracellular matrix, other functions of these cells are only now beginning to be appreciated. We hypothesize that exposure to interleukin-18 will stimulate other aspects of fibroblast behavior important in myocardial remodeling including proliferation, migration and collagen reorganization. Fibroblasts were isolated from adult male rat hearts and bioassays performed to determine the effects of interleukin-18 on fibroblast function. Treatment of fibroblasts with interleukin-18 (1-100ng/ml) resulted in increased production of extracellular matrix components and remodeling or contraction of three-dimensional collagen scaffolds by these cells. Furthermore, exposure to interleukin-18 stimulated fibroblast migration and proliferation. Treatment of heart fibroblasts with interleukin-18 resulted in the rapid activation of the c-Jun N-terminal kinase (JNK) and phosphoinositide 3-kinase (PI3-kinase) pathways. Studies with pharmacological inhibitors illustrated that activation of these pathways is critical to interleukin-18 mediated alterations in fibroblast function. These studies illustrate that interleukin-18 plays a role in modulation of cardiac fibroblast function and may be an important component of the inflammation-fibrosis cascade during pathological myocardial remodeling.


Subject(s)
Fibroblasts/drug effects , Fibroblasts/metabolism , Gene Expression Regulation/drug effects , Interleukin-18/pharmacology , Myocardium/cytology , Animals , Biological Assay , Cell Movement/drug effects , Cell Proliferation/drug effects , Cell Separation , Collagen/metabolism , Enzyme Activation/drug effects , Extracellular Matrix Proteins/genetics , Extracellular Matrix Proteins/metabolism , Fibroblasts/cytology , Fibroblasts/enzymology , Gels , Integrins/genetics , Integrins/metabolism , JNK Mitogen-Activated Protein Kinases/metabolism , Male , Matrix Metalloproteinase 2/metabolism , Phosphatidylinositol 3-Kinase/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Rats , Rats, Sprague-Dawley , Signal Transduction/drug effects
5.
Cell Tissue Res ; 340(1): 117-26, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20217135

ABSTRACT

Increases in cardiovascular load (pressure overload) are known to elicit ventricular remodeling including cardiomyocyte hypertrophy and interstitial fibrosis. While numerous studies have focused on the mechanisms of myocyte hypertrophy, comparatively little is known regarding the response of the interstitial fibroblasts to increased cardiovascular load. Fibroblasts are the most numerous cell type in the mammalian myocardium and have long been recognized as producing the majority of the myocardial extracellular matrix. It is only now becoming appreciated that other aspects of fibroblast behavior are important to overall cardiac function. The present studies were performed to examine the temporal alterations in fibroblast activity in response to increased cardiovascular load. Rat myocardial fibroblasts were isolated at specific time-points (3, 7, 14, and 28 days) after induction of pressure overload by abdominal aortic constriction. Bioassays were performed to measure specific parameters of fibroblast function including remodeling and contraction of 3-dimensional collagen gels, migration, and proliferation. In addition, the expression of extracellular matrix receptors of the integrin family was examined. Myocardial hypertrophy and fibrosis were evident within 7 days after constriction of the abdominal aorta. Collagen gel contraction, migration, and proliferation were enhanced in fibroblasts from pressure-overloaded animals compared to fibroblasts from sham animals. Differences in fibroblast function and protein expression were evident within 7 days of aortic constriction, concurrent with the onset of hypertrophy and fibrosis of the intact myocardium. These data provide further support for the idea that rapid and dynamic changes in fibroblast phenotype accompany and contribute to the progression of cardiovascular disease.


Subject(s)
Cardiomyopathies/pathology , Cardiomyopathies/physiopathology , Fibroblasts/pathology , Hypertension/complications , Myocardium/pathology , Animals , Aorta, Abdominal/surgery , Cell Movement/physiology , Cell Proliferation , Disease Models, Animal , Disease Progression , Extracellular Matrix/metabolism , Fibroblasts/metabolism , Fibrosis/etiology , Fibrosis/pathology , Fibrosis/physiopathology , Hypertrophy, Left Ventricular/pathology , Hypertrophy, Left Ventricular/physiopathology , Integrins/metabolism , Male , Myocardial Contraction , Pressure/adverse effects , Rats , Rats, Sprague-Dawley , Stroke Volume/physiology , Time Factors , Ventricular Remodeling/physiology
6.
Microsc Microanal ; 14(2): 117-25, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18312716

ABSTRACT

Patterning of cells is critical to the formation and function of the normal organ, and it appears to be dependent upon internal and external signals. Additionally, the formation of most tissues requires the interaction of several cell types. Indeed, both extracellular matrix (ECM) components and cellular components are necessary for three-dimensional (3-D) tissue formation in vitro. Using 3-D cultures we demonstrate that ECM arranged in an aligned fashion is necessary for the rod-shaped phenotype of the myocyte, and once this pattern is established, the myocytes were responsible for the alignment of any subsequent cell layers. This is analogous to the in vivo pattern that is observed, where there appears to be minimal ECM signaling, rather formation of multicellular patterns is dependent upon cell-cell interactions. Our 3-D culture of myocytes and fibroblasts is significant in that it models in vivo organization of cardiac tissue and can be used to investigate interactions between fibroblasts and myocytes. Furthermore, we used rotational cultures to examine cellular interactions. Using these systems, we demonstrate that specific connexins and cadherins are critical for cell-cell interactions. The data presented here document the feasibility of using these systems to investigate cellular interactions during normal growth and injury.


Subject(s)
Cell Communication , Cell Culture Techniques , Fibroblasts/physiology , Imaging, Three-Dimensional , Myocardium/cytology , Myocytes, Cardiac/physiology , Animals , Animals, Newborn , Cell Adhesion , Cell Movement , Extracellular Matrix/metabolism , Microscopy, Confocal , Microscopy, Fluorescence , Rats
7.
Proc Natl Acad Sci U S A ; 101(30): 10919-24, 2004 Jul 27.
Article in English | MEDLINE | ID: mdl-15263086

ABSTRACT

The androgen testosterone is essential for the Sertoli cell to support the maturation of male germ cells and the production of spermatozoa (spermatogenesis). In the classical view of androgen action, binding of androgen to the intracellular androgen receptor (AR) produces a conformational change in AR such that the receptor-steroid complex has high affinity for specific DNA regulatory elements and is able to stimulate gene transcription. Here, we demonstrate that testosterone can act by means of an alternative, rapid, and sustainable mechanism in Sertoli cells that is independent of AR-DNA interactions. Specifically, the addition of physiological levels of testosterone to Sertoli cells stimulates the mitogen-activated protein kinase signaling pathway and causes phosphorylation of the cAMP response element binding protein transcription factor on serine 133, a modification known to be required for Sertoli cells to support spermatogenesis. Androgen-mediated activation of mitogen-activated protein kinase and cAMP response element binding protein occurs within 1 min, extends for at least 12 h and requires AR. Furthermore, androgen induces endogenous cAMP response element binding protein-mediated transcription in Sertoli cells. These newly identified mechanisms of androgen action in Sertoli cells suggest new targets for developing male contraceptive agents.


Subject(s)
Cyclic AMP Response Element-Binding Protein/metabolism , Mitogen-Activated Protein Kinases/metabolism , Sertoli Cells/metabolism , Testosterone/pharmacology , Animals , Base Sequence , Cyclic AMP/physiology , Cyclic AMP Response Element-Binding Protein/drug effects , DNA Primers , Enzyme Activation/drug effects , Kinetics , Male , Phosphorylation , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction , Sertoli Cells/drug effects
8.
J Biol Chem ; 279(16): 16064-70, 2004 Apr 16.
Article in English | MEDLINE | ID: mdl-14761970

ABSTRACT

Id (inhibitor of DNA binding/differentiation) proteins repress differentiation and promote cell division by dimerizing with and inhibiting the action of basic helix-loop-helix transcription factors including those that bind to E-box motifs. Of the four characterized Id proteins, only Id2 is found in the nucleus of Sertoli cells that support the development of spermatozoa in the testis. Differential display analysis of rat primary Sertoli cell mRNA identified Id2 as being inducible by forskolin, a stimulator of cAMP production. Northern blot analysis confirmed that Id2 mRNA expression peaked in Sertoli cells 6-12 h after stimulation with forskolin or follicle-stimulating hormone (FSH), the major physiological stimulator of cAMP in Sertoli cells. Similarly, Id2 promoter activity in Sertoli cells was induced after forskolin or FSH stimulation as well as by overexpression of protein kinase A. Forskolin induction of the Id2 promoter required sequences located between positions -122 and -82. Protein(s) of 40-45 kDa were found to bind two activated transcription factor/cAMP-response element-like sites and a GATA motif within the regulatory region. The induction of the Id2 gene by FSH corresponded with a decrease in protein binding to an E-box consensus motif and decreased E-box-mediated transcription. Together, these findings raise the possibility that FSH-mediated induction of Id2 and resultant inhibition of basic helix-loop-helix transcription factor-regulated genes in Sertoli cells may contribute to the regulation of spermatogenesis.


Subject(s)
Cyclic AMP/pharmacology , DNA-Binding Proteins/genetics , Follicle Stimulating Hormone/pharmacology , Gene Expression Regulation/drug effects , Sertoli Cells/metabolism , Transcription Factors/genetics , Animals , Cell Differentiation/genetics , Cells, Cultured , DNA-Binding Proteins/metabolism , Inhibitor of Differentiation Protein 2 , Male , Rats , Rats, Sprague-Dawley , Repressor Proteins/genetics , Sertoli Cells/cytology , Spermatogenesis/drug effects , Spermatogenesis/genetics , Transcription Factors/metabolism , Transcription, Genetic/drug effects , Transcription, Genetic/genetics
9.
Mol Cell Endocrinol ; 201(1-2): 1-12, 2003 Mar 28.
Article in English | MEDLINE | ID: mdl-12706288

ABSTRACT

Germ cell development within the mammalian testis requires testosterone stimulation of somatic Sertoli cells via interaction with intracellular androgen receptors (AR). AR expression levels undergo marked changes during spermatogenesis suggesting that the modulation of AR expression is an important mechanism to regulate Sertoli cell responsiveness to testosterone. An analysis of the AR gene promoter revealed three kappaB enhancer elements that interacted with Sertoli cell p50 and RelA NF-kappaB proteins, and the overexpression of these NF-kappaB subunits in Sertoli cells stimulated AR promoter activity. Moreover, TNF-alpha, a secretory product of round spermatids, stimulated NF-kappaB binding to the AR promoter, induced AR promoter activity, and increased endogenous AR expression in primary cultures of Sertoli cells. Given the requirement of testosterone for spermatogenesis and the importance of AR in mediating Sertoli cell responsiveness to testosterone, the stimulation of AR expression by NF-kappaB and TNF-alpha may represent an important regulatory mechanism required to maintain efficient spermatogenesis.


Subject(s)
Gene Expression Regulation , NF-kappa B/pharmacology , Promoter Regions, Genetic/genetics , Receptors, Androgen/genetics , Sertoli Cells/drug effects , Tumor Necrosis Factor-alpha/pharmacology , Androgens/pharmacology , Animals , Blotting, Northern , Blotting, Western , Cells, Cultured , Enhancer Elements, Genetic , Male , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Androgen/metabolism , Sertoli Cells/metabolism , Transcription, Genetic , Transcriptional Activation , Transfection
10.
Biol Reprod ; 66(3): 659-66, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11870072

ABSTRACT

In the mammalian testis, the binding of FSH to Sertoli cells activates the cAMP-dependent protein kinase A signaling pathway, resulting in the phosphorylation of the cAMP response element binding protein (CREB). Previous studies have also shown that CREB gene expression is activated by cAMP in Sertoli cells and that 2 cAMP response elements (CREs) that bind CREB and a neighboring Sp1 binding site are required for basal and cAMP-inducible CREB promoter activity. In contrast, CREB expression has been less well characterized in testis germ cells. We demonstrated that CREB and Sp1 are expressed in early germ cells only through the midpachytene stage of spermatogenesis. Furthermore, CREB promoter activity was induced over 70-fold by transient overexpression of Sp1 in SL2 cells, suggesting that Sp1 is an important regulator of CREB expression. Further studies of the CREB promoter revealed an additional regulatory element in the -130 region between the Sp1 and CREB transcription factor binding sites that is necessary for full promoter activity. Proteins expressed in Sertoli cells and germ cells bind specifically to the newly identified regulatory region. These studies suggest that proteins binding to Sp1 motifs and the -130 region are required to activate the CREB promoter.


Subject(s)
Cyclic AMP Response Element-Binding Protein/genetics , Gene Expression Regulation/drug effects , Sp1 Transcription Factor/pharmacology , Testis/metabolism , Animals , Binding Sites , DNA/chemistry , DNA/metabolism , Drosophila/metabolism , Gene Expression , Glutathione Transferase , Male , Nuclear Proteins/metabolism , Promoter Regions, Genetic , Rats , Regulatory Sequences, Nucleic Acid , Sertoli Cells/metabolism , Sp1 Transcription Factor/genetics , Spermatogenesis , Spermatozoa/metabolism , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...